Significance of HBV DNA levels in liver histology of HBeAg and anti-HBe positive patients with chronic hepatitis B

American Journal of Gastroenterology

Volumn 99, Issue 10, 2004, Pages 2032-2037

  Yuen, Man Fung ^b   Ng, Irene Oi Lin ^b   Fan, Sheung Tat ^b   Yuan, He Jun ^b   Wong, Danny Ka Ho ^b   Yuen, John Chi Hang ^b   Sum, Simon Siu Man ^b   Chan, Annie On On ^b   Lai, Ching Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER LEVEL; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; PARAMETER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; DNA, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED;

EID: 7044241297     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40440.x     Document Type: Article

References (26)

1. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987;7:758-63.
2. Lai CL, Ratziu V, Yuen MF. Viral hepatitis B. 2003;362:2089-94.
3. Yuen MF, Yuan HJ, Hui CK, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: Implications for antiviral therapy. Gut 2003;53:416-9.
4. Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7.
5. McMahon BJ, Holck P, Bulkow L, et al. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001;135:759-68.
6. Yuen MF, Lai CL. Treatment for chronic hepatitis B. Lancet Infect Dis 2001;1:232-41.
7. Niitsuma H, Ishii M, Miura M, et al. Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Am J Gastroenterol 1997;92:119-23.
8. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - Summary of a workshop. Gastroenterology 2001;120:1828-53.
9. Chu CJ, Lok AS. Clinical utility in quantifying serum HBV DNA levels using PCR assays. J Hepatol 2002;36:549-51.
10. Yuen MF, Lai CL. Debates in hepatitis: How to assess HBV DNA reductions in association with therapy. Viral Hepat Rev 1999;5:159-75.
11. Dusheiko G, Paterson A. Hepatitis B core and surface antigen expression in HBeAg and HBV DNA positive chronic hepatitis B: Correlation with clinical and histological parameters. Liver 1987;7:228-32.
12. Cahen DL, van Leeuwen DJ, ten Kate FJ, et al. Do serum ALT values reflect the inflammatory activity in the liver of patients with chronic viral hepatitis? Liver 1996;16:105-9.
13. Agalar C, Diri C, Usubutun S, et al. The role of HBV DNA and liver histopathology in HBsAg carriers. Hepatogastroenterology 1997;44:1196-9.
14. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
15. Yuen MF, Sablon E, Yuan HJ, et al. The relationship between the development of precore and core promoter mutations and HBeAg seroconversion in chronic hepatitis B. J Infect Dis 2002;186:1335-8.
16. Matinot-Peignoux M, Boyer N, Colombat M, et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002;36:543-6.
17. Lindh M, Horal P, Dhillon AP, et al. Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepat 2000;7:258-67.
18. Zavaglia C, Mondazzi L, Maggi G, et al. Are alanine amino-transferase, hepatitis B virus DNA or IgM antibody to hepatitis B core antigen serum levels predictors of histological grading in chronic hepatitis B? Liver 1997;17:83-7.
19. Manesis EK, Papatheodoridis GV, Hadziyannis SJ. Serum HBV-DNA levels in inactive hepatitis B virus carriers. Gastroenterology 2002;122:2092-3.
20. Manesis EK, Papatheodoridis GV, Sevastianos V, et al. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 2003;98:2261-7.
21. Chu CJ, Hussain M, Lok ASF. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36:1408-15.
22. Karayiannis P, Fowler MJ, Lok AS, et al. Detection of serum HBV-DNA by molecular hybridization. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol 1985;1:99-106.
23. Bonino F, Rosina F, Rizzetto M, et al. Gastroenterology 1986;90:1268-73.
24. Kidd AH, Kidd-Ljunggren K. A revised secondary structure model for the 3′-end of hepatitis B virus pregenomic RNA. Nucleic Acid Res 1996;24:3295-301.
25. Li J, Buckwold VE, Hon MW, et al. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 1999;73:1239-44.
26. Buckwold VE, Xu Z, Chen M, et al. Effects of a naturally occurred mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996;70:5845-51.